PubMed Central, Li, Li, et al
A dose-dependent inverted U-shaped response to DHEAS is observed on tests of learning and memory function in male mice (317, 318)
Treatment begins with a dose-escalation schedule (0.6 mg weekly increments to 3.0 mg as tolerated) and should be discontinued after 12 weeks at the 3.0 mg dose if at least 5% weight loss has not been achieved
Typical symptoms include fatigue, weakness, pale skin, shortness of breath, and neurological manifestations such as numbness, tingling in the extremities, memory problems, and difficulty walking
Il vous questionnera sur votre tat de sant (pathologies, allergies) pour savoir s'il peut ou non vous prescrire de la vitamine B12
HER2 transmembrane domain (TMD) mutations (V659/G660) that stabilize homo- and heterodimerization are rare oncogenic drivers in lung adenocarcinoma that respond to afatinib